Article Information
History
- May 23, 2020.
Article Versions
- Version 1 (May 16, 2020 - 16:24).
- Version 2 (May 21, 2020 - 11:23).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Jessica Rothman1,*,
- David Eidelberg, M.D.2,
- Samantha Rothman3,
- Theodore Holford, Ph.D.4 and
- Douglas L Rothman, Ph.D.5
- 1Department of Biostatistics. Ph.D. Student. Yale University School of Public Health, New Haven, CT
- 2Center for Neurosciences, Institute of Molecular Medicine, Northwell Health, Manhasset, New York
- 3Departments of Mathematics and Computer Science. Tulane University, New Orleans, LA
- 4Departments of Biostatistics, and Statistics and Data Science. Yale University School of Public Health and Yale University Graduate School of Arts and Sciences, New Haven, CT
- 5Departments of Radiology and Biomedical Engineering. Yale University School of Medicine, New Haven, CT
- ↵*Corresponding Author; email: jessica.rothman{at}yale.edu
Posted May 23, 2020.
Analysis of the time and age dependence of the case-fatality-ratio for COVID-19 in seven countries with a high total-to-positive test ratio suggests that the true CFR may be significantly underestimated for the United States in current models
